20. June 2012
DASGIP Parallel Bioreactor Systems and Eppendorf New Brunswick Bioreactor Technology
Juelich, June 18, 2012 – DASGIP Information and Process Technology GmbH, leading manufacturer of Parallel Bioreactor Systems and software solutions for bioprocessing , is integrating Eppendorf’s New Brunswick bioreactor technologies into its bioprocess control. Following the acquisition of DASGIP by Eppendorf AG in January of this year, the company thus emphasizes the strong synergy resulting from the combination of both firms.
At this year’s Achema (June 18-22, 2012) DASGIP introduces for the first time the integration of the 5 liter single-use bioreactor CelliGen BLU into the DASGIP system. The simultaneously presented integration of the bioreactor control units BioFlo/CelliGen 115 and 310 and CelliGen BLU into the DASGIP Control software further allows New Brunswick users in cell culture and microbiology the option of using DASGIP’s comprehensive software suite DASware for bioprocess development.
The integration of the CelliGen BLU single-use vessel into the DASGIP system combines the advantages of the New Brunswick single-use bioreactors with DASGIP’s established parallel processing and comprehensive data management. Up to 16 bioreactors con be operated in parallel, process parameters such as temperature and agitation, pH and dissolved oxygen are precisely monitored and controlled. The inclusion of the CelliGen BLU 5L vessel enables flexible and reproducible processing in cell culture under the control of tried and true DASGIP.
The support of the New Brunswick bioreactor control units CelliGen/ BioFlo 115 & 310 and CelliGen BLU, provided by the software DASware migrate, introduced last year, offers the use of DASGIP’s “all in one” software solutions to users of New Brunswick technology for their bioprocessing needs. Further to the simultaneous control of several bioreactors and intelligent data management, users benefit from the FDA’s “Quality by design” concept during process development.
DASGIP has been a part of Eppendorf AG since the beginning of 2012. “The expansion of our software DASware migrate for driving Eppendorf’s New Brunswick single-use bioreactors is a further example of the perfect match between Eppendorf and DASGIP”, commented Dr. Falk Schneider, member of DASGIP management and head of software development. “The combination of our software expertise with the established benchtop bioreactors by New Brunswick opens up completely new possibilities of process control.”
» Download the press release of June 18, 2012 (pdf)
» Download our product flyer: Integration of CelliGen and BioFlo (pdf)
